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Epidermal growth factor receptor (EGFR), a receptor often expressed in nasopharyngeal carcinoma (NPC) cells, is one of the recently identified
molecular targets in cancer treatment. In the present study, the effects of combined treatment of Zn-BC-AM PDT with an EGFR inhibitor
AG1478 were investigated. Well-differentiated NPC HK-1 cells were subjected to PDT with 1mM of Zn-BC-AM and were irradiated at a light
dose of 1 J/cm2 in the presence or absence of EGFR inhibitor AG1478. Specific protein kinase inhibitors of downstream EGFR targets were also
used in the investigation. EGFR, Akt, and ERK were found constitutively activated in HK-1 cells and the activities could be inhibited by the
EGFR inhibitor AG1478. A sub-lethal concentration of AG1478 was found to further enhance the irreversible cell damage induced by Zn-BC-
AM PDT in HK-1 cells. Pre-incubation of the cells with specific inhibitors of EGFR (AG1478), PI3k/Akt (LY294002), or MEK/ERK (PD98059)
before light irradiation were found to enhance Zn-BC-AM PDT-induced formation of apoptotic cells. The efficacy of Zn-BC-AM PDT can
be increased through the inhibition of EGFR/PI3K/Akt and EGFR/MEK/ERK signaling pathways in NPC cells. Combination therapy
with Zn-BC-AM PDT and EGFR inhibitors may further be developed for the treatment of advanced NPC. J. Cell. Biochem. 9999: 1–8,
2009.  2009 Wiley-Liss, Inc.KEY WORDS: EGFR; NPC; PHOTODYNAMIC THERAPYE pidermal growth factor receptor (EGFR) is a member of ErbBfamily of tyrosine kinase receptors (RTKs). The transmem-
brane protein receptor is activated by specific ligands, including
epidermal growth factor (EGF) and transforming growth factor-a
(TGF-a) [Yarden, 2001]. EGFR is frequently overexpressed and found
in many types of human cancers such as lung, breast, prostate,
colorectal, and head and neck cancer [Sunnerhagen et al., 1993;
Salomon et al., 1995; Mendelsohn, 2002]. Hyper-activation of EGFR
pathway is often seen in cancer cells overexpressing EGFR [Hirsch
et al., 2003] or overproducing the ligands [Prenzel et al., 1999]. This
result in the promotion of malignant transformation and tumor
growth by inhibiting the apoptotic mechanism, regulating the cell
cycle, angiogenesis and metastasis [Baselga, 2001, 2002; El Rayes
et al., 2004].
Nasopharyngeal carcinoma (NPC) has a high prevalence in Hong
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signaling pathway by specific pharmacological inhibitors or down-
regulation of EGFR using monoclonal antibodies was found to
effectively induce cell cycle arrest and suppress cell proliferation in
different NPC cell lines [Zhu et al., 2001; Sung et al., 2005, 2006;
Huang et al., 2007]. In addition, the use of monoclonal antibody to
inhibit EGFR appears to enhance the sensitivity to chemotherapy in
late stage NPC patients [Chan et al., 2005]. However, the apoptosis-
enhancing effect through the EGFR inhibition in NPC cells was not
previously demonstrated.
Due to the complexity of the disease, new treatment methods for
locoregionally advanced or metastatic NPC are currently under
development. Photodynamic therapy (PDT), a recently developed
method for effective cancer treatment, may be used as an alternative
to treat the recurrent and advanced NPC with fewer side effects. It is
now clear that PDT can be applied as a single therapy or in1
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combination with chemotherapeutic agents for cancer treatments.
We have previously studied the mechanisms of PDT-induced cell
death of NPC cells [Yow et al., 2000a,b; Mak et al., 2003, 2004; Koon
et al., 2006; Li et al., 2006]. We found that PDT induces apoptosis of
NPC cells. Here, we show that Zn-BC-AM PDT-induced apoptosis of
the HK-1 NPC cells would be enhanced by inhibition of EGFR/MEK/
ERK and EGFR/PI3K/AKT signaling pathways.MATERIALS AND METHODS
MATERIALS
Photosenzitizer Zn-BC-AM was used in this study [Mak et al., 2004].
The inhibitors of EGFR (AG1478) and MEK/ERK (PD98059) were
purchased from Calbiochem. PI3k/Akt inhibitor (LY294002) was
purchased from Sigma. Antibodies specific for EGFR, phospho-
EGFR Tyr1068 (p-EGFR), Akt, phospho-Akt Ser473 (p-Akt), p44/
22 MAPK (ERK1 and ERK2), phospho-p44/42 MAPK Thr202/Tyr204
(p-ERK1 and p-ERK2), caspase-3, Bcl-xL, Bax, and b-actin were
purchased from Cell Signaling Technology. Bcl-2 antibody was
purchased from Dako.
CELL CULTURE
HK-1 cells were maintained in RPMI 1640 medium (GIBCO)
supplemented with 10% FBS (GIBCO) and antibiotics penicillin
(50 units/ml) and streptomycin (50mg/ml) (GIBCO). The cells were
maintained and incubated in a humidified 5% CO2 incubator at
378C.
Zn-BC-AM PDT TREATMENT
A stock solution of Zn-BC-AM (5 mM) was prepared in dimethyl
sulfoxide (DMSO), and the stock solution was stored at 208C in
dark. HK-1 cells (3 105 cells/dish) in 35 mm Petri dish were
incubated overnight. The cells were then incubated with Zn-BC-AM
(1mM) at 378C in the dark for 24 h. Medium containing Zn-BC-AM
was replaced with fresh medium before light irradiation. NPC cells
were irradiated by light at an intensity of 0.7–0.8 mW/cm2 from a
projector equipped with a 400-W tungsten lamp and a heat isolation
filter and narrow band filter (682 5 nm) [Mak et al., 2004]. After
light irradiation, the cells were incubated in a 5% CO2 incubator at
378C until further investigation.
PROPIDIUM IODIDE EXCLUSION ASSAY
Cell viability was determined as previously described [Do et al.,
2003]. Both adherent and floating cells were collected at 24 h post-
PDT. The cells were then incubated with propidium iodide (PI, 5mg/
ml in PBS) in dark for 5 min. The cells were then immediately
analyzed by FACSCalibur (Becton Dickson) with the excitation
wavelength at 488 nm. Fluorescent signals were collected by the
FL-2 channel. Data were further analyzed by the CellQuest software.
CLONOGENICITY ASSAY
Clonogenicity was performed as previously described [Tsai
et al., 2004]. Briefly, PDT-treated HK-1 cells were trypsinized and
collected by centrifugation (700g, 5 min). Various concentrations of
cells were seeded onto 35 mm Petri dishes and colony formation was2 NASOPHARYNGEALQ2 CARCINOMA CELLSdetermined 7 days after incubation. The cell monolayers were then
washed twice with PBS and fixed with absolute methanol for 10 min.
The cells were stained with 0.5% of crystal violet for 10 min and
rinsed four times with tap water. After air drying, the images and the
number of colonies in each dish were captured and analyzed with
software Quantity-One (Bio-Rad).NUCLEAR STAINING WITH HOECHST 33342
Cells were grown on coverslip and subjected to PDT as described
above. Cells were treated with 20mg/ml of Hoechst 33342 for 30 min
before harvesting. Both adherent and floating cells were collected
for analysis. Fluorescence image of the stained nucleus was
observed under the fluorescence microscope.WESTERN BLOTTING ANALYSIS
Total cell lysates were prepared by lysing the cells with the lysis
buffer containing 50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1% NP-40
(USB), 1% phosphatase inhibitors cocktail (Calbiochem), and 0.25%
protease inhibitors cocktail (Sigma). Cell debris was removed by
centrifuging the cell lysates at 10,000g at 48C for 10 min. Protein
concentrations were determined using the detergent compatible
protein assay kit (Bio-Rad). Cellular proteins were then separated
by SDS–PAGE, and the separated proteins were electro-blotted to
polyvinylidene difluoride (PVDF) membrane (Perkin Elmer) in a
transfer buffer containing 50 mM Tris, 150 mM glycine, 0.05% SDS,
and 20% methanol. The membrane was blocked in 5% non-fat dry
milk in TBST containing 25 mM Tris, 140 mM NaCl, 3 mM KCl, and
0.1% Tween-20. The membrane was then incubated with primary
antibody for 2 h at room temperature. After washing with TBST, the
membrane was incubated with an appropriately diluted secondary
antibody conjugated with horseradish peroxidase for 1 h at room
temperature. Chemiluminescence was detected using the Western
blotting substrate (Lab Frontier) and visualized on an X-ray film.
ImageJ software was used to measure the densitometry of bands
generated from Western blot analysis.STATISTICAL ANALYSIS
Student’s t-test was used to analyze the level of significance in this
study.RESULTS
EFFECTS OF EGFR INHIBITOR AG1478 ON HK-1 CELLS
Expression of EGFR is common in both NPC tissues and NPC cell
lines. Recent studies show that HK-1 cell line expresses a higher level
of EGFR than the other NPC cell lines [Sung et al., 2005]. However,
the effect of inhibition of EGFR signaling pathway in PDT-induced
HK-1 cell death is unknown. In this study, we first evaluated the
cytotoxicity of the EGFR inhibitor AG1478 on HK-1 cells. HK-1 cells
were incubated with various concentrations of AG1478 (0–10mM)
for 24 h and the cytotoxicity of AG1478 was evaluated by PI
exclusion assay. Results in Figure 1A showed that the percentage of
PI stained cells was increased in a dose-dependent manner. At theJOURNAL OF CELLULAR BIOCHEMISTRY
Fig. 1. Inhibition of EGFR induces cell death and inactivates Akt and ERK in
HK-1 cells. A: HK-1 cells were treated with AG1478 (0–10mM) as described in
the Materials and Methods Section. Cell viability was examined 24 h after
treatment. Each data point represents the mean SD (n¼ 3). B: Western
blotting analysis of p-EGFR, p-Akt, and p-ERK1/2 in HK-1 cells following 2 h
treatment with AG1478 (10mM).
Fig. 2. Inhibition of EGFR enhanced the sensitivity of HK-1 cells to Zn-BC-
AM PDT. HK-1 cells were incubated with Zn-BC-AM (1mM) for 24 h. Before
light irradiation, the cells were pre-treated with AG1478 (10mM) for 1 h.
A: Effect of AG1478 alone, PDT (1 J/cm2) and combined treatment on cell
viability at 24 h post-treatment. B: Determination of cell viability at 24 h post-
PDT with different light doses (0.25–1 J/cm2). C: Evaluation of colony forming
ability at 7 days after PDT. Each data point represents the mean SD (n¼ 3).
P< 0.05 versus corresponding PDT treatment.concentration of 10mM, the percentage of cytotoxicity of AG1478
on HK-1 cells was 17.5%. At this concentration, AG1478 was found
to exert a low level of cytotoxicity on HK-1 cells. It is well
documented that EGFR activates survival signaling pathways
namely PI3K/Akt [Chan et al., 1999; Vivanco and Sawyers, 2002]
and ERKs [Lewis et al., 1998]. In order to elucidate the downstream
pathways of EGFR in HK-1 cells, the cells were incubated with
10mM of AG1478 for 2 h. Total cell lysates were then collected
and the state of phosphorylation of EGFR, Akt, and ERKs were
determined by Western blotting (Fig. 1B). p-EGFR, p-Akt, and
p-ERK1/2 were all found to be expressed in the untreated HK-1 cells.
After incubation with a sub-lethal concentration of AG1478
(10mM), the expression level of p-EGFR, p-Akt, and p-ERK1/2
was greatly decreased. This result suggested that Akt and ERKs are
constitutively activated by EGFR in HK-1 cells and the activation
can be inhibited by a sub-lethal concentration of AG1478.
EFFECTS OF AG1478 ON Zn-BC-AM PDT-INDUCED CELL DEATH
As EGFR constitutively activates the survival signaling pathways in
HK-1 cells, we further examined whether inhibition of the EGFR
signaling pathways would enhance the cytotoxicity of Zn-BC-AMJOURNAL OF CELLULAR BIOCHEMISTRYPDT. In this study, Zn-BC-AM-treated HK-1 cells were pre-
incubated with AG1478 (10mM) for 1 h before light irradiation
(0.25–1 J/cm2). Samples were collected at 24 h post-Zn-BC-AM PDT
and the cell survival was determined by flow cytometry. One hour of
AG1478 pre-treatment exerted only a low level of cytotoxicity on
the HK-1 cells (Fig. 2A). At the light dose of 1 J/cm2, pre-treatment
of HK-1 cells with AG1478 was found to significantly increase the
cytotoxicity of Zn-BC-AM PDT from 37.7% to 66.0% (P< 0.05).NASOPHARYNGEALQ2 CARCINOMA CELLS 3
AG1478 also increased the percentage of cell death within the light
dose of 0.25–1 J/cm2 (Fig. 2B). Clonogenicity assay was used to
further confirm the enhancing effect of AG1478 on Zn-BC-AM PDT-
induced cell death. Within the light dose of 0.25–1 J/cm2, a light
dose-dependent reduction of colony formation was observed
(Fig. 2C). AG1478 pre-treatment further reduces the number of
colony formation in PDT-treated HK-1 cells (P< 0.05). Taken
together, inhibition of EGFR signaling pathways can enhance the
cytotoxicity of Zn-BC-AM PDT in HK-1 cells.
ENHANCEMENT OF Zn-BC-AM PDT-INDUCED APOPTOSIS
BY AG1478
It has been previously demonstrated that Zn-BC-AM PDT induces
apoptosis in NPC cells [Mak et al., 2004]. In this study, we further
examined whether AG1478 would enhance Zn-BC-AM PDT-
induced apoptosis of HK-1 cells. Experiment was conducted to
determine the formation of apoptotic cells after PDT (Fig. 3A).
Formation of apoptotic cells was not observed in untreated orFig. 3. Zn-BC-AM PDT synergizes with AG1478 to induce apoptosis in HK-1 cells. H
(1 J/cm2), the cells were pre-treated with AG1478 (10mM) for 1 h. A: Staining of apopto
33342 at 4 h post-Zn-BC-AM PDT. Samples were visualized under a Zeiss fluorescence m
each condition. Each data point represents the mean SD (n¼ 3). C: Western blotting an
were harvested at 2 and 4 h after light irradiation. D: Band intensity profile of caspase
P< 0.05 versus PDT.
4 NASOPHARYNGEALQ2 CARCINOMA CELLSAG1478-treated HK-1 cells. After PDT, the percentage of apoptotic
cells was increased to 25.3% (Fig. 3B). Pre-treatment of HK-1 cells
with AG1478 further increased the percentage of apoptotic cell to
46.4% (P< 0.05). Proteolytic cleavage of the executioner caspase-3
is one of the hallmarks of apoptosis [Ali et al., 2001; Takahashi et al.,
2003]. We then examined the effects of AG1478 on the proteolytic
cleavage of caspase-3. Compared with the PDT group, proteolytic
cleavage product (p19) was clearly detected in cells treated with
AG1478 and Zn-BC-AM PDT-treated HK-1 cells at 2 h after
treatment (Fig. 3C,D). These observations suggested that pharma-
cological inhibition of the EGFR would enhance the formation of
apoptotic cells.
EFFECT OF PHARMACOLOGICAL INHIBITION OF EGFR
DOWNSTREAM PATHWAYS ON Zn-BC-AM PDT-INDUCED
APOPTOSIS IN HK-1 CELLS
Since the endogenously activated Akt and ERKs would be inhibited
by AG1478, we examined the effect of EGFR inhibition on theK-1 cells were incubated with Zn-BC-AM (1mM) for 24 h. Before light irradiation
tic cells. Both floating and adherent PDT-treated HK-1 cells were stained with Hoechst
icroscope (40). B: Percentage of apoptotic cells. At least 400 cells were counted for
alysis of proteolytic cleavage of caspase-3 in Zn-BC-AM PDT-treated HK-1 cells. Cells
-3. Each bar represents the mean SD (n¼ 2). #<0.05 versus untreated cell control,
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Fig. 4. Effect of AG1478 on of the expression of p-Akt and p-ERK1/2. HK-1
cells were incubated with Zn-BC-AM (1mM) for 24 h. Before light irradiation
(1 J/cm2), the cells were pre-treated with AG1478 (10mM) for 1 h. A: Cells
were harvested at 2 and 4 h post-PDT. Expression of p-Akt and p-ERK1/2 was
analyzed by Western blotting method. B,C: Band intensity profiles of p-Akt/Akt
and p-ERK/ERK. Results were expressed as the mean SD (n¼ 3). #<0.05
versus untreated cell control, P< 0.05 versus PDT.
Fig. 5. Effect of AG1478, LY294002, and PD98059 on Zn-BC-AM PDT-
induced apoptosis of HK-1 cells. HK-1 cells were incubated with Zn-BC-AM
(1mM) for 24 h. Before light irradiation (1 J/cm2), the cells were pre-treated
with AG1478 (10mM), LY294002 (10mM), or PD98059 (40mM) for 1 h.
A: Cell viability was determined at 24 h post-PDT. B: Nuclear staining of
apoptotic cells at 4 h post-PDT. C: Percentage of apoptotic cells. At least 400
cells were counted for each condition. Each data point represents the
mean SD (n¼ 3). P< 0.05 versus PDT alone.expression of p-Akt and p-ERK1/2 in PDT-treated HK-1 cells (Fig. 4).
First of all, AG1478 alone was found to reduce the expression of p-
Akt in untreated HK-1 cell. An increase in p-Akt was observed at 2–
4 h post-PDT. Combined treatment of cells with AG1478 and PDT
resulted in the reduced expression of p-Akt. It is worthy to note that
the absolute amount of total Akt in AG1478þ PDT-treated HK-1
cells was lower than the untreated HK-1 cells. For the ERK1/2
pathway, AG1478 alone was found to totally suppress theJOURNAL OF CELLULAR BIOCHEMISTRYexpression of p-ERK1/2 in the untreated HK-1 cells. The expression
level of p-ERK1/2 was decreased at 2–4 h post-PDT. The expression
level of p-ERK1/2 was remaining low after combination treatment
of cells with AG1478 and PDT. To further substantiate the role of
Akt and ERKs in PDT-induced HK-1 apoptosis, pharmacological
inhibitors for Akt and MEK/ERKs were used. The formation of
apoptotic cells was also determined at 4 h post-PDT (Fig. 5A). No
appreciable formation of apoptotic cells was found in the untreatedNASOPHARYNGEALQ2 CARCINOMA CELLS 5
Fig. 6. Effects of inhibition of the EGFR signaling pathways on the expres-
sion of Bcl-2 family proteins. HK-1 cells were PDT-treated as described in
Figure 5. Cells were harvested at 4 h post-PDT. A: Expression of the anti-
apoptotic (Bcl-xL and Bcl-2) and the pro-apoptotic (Bax) proteins. The ratio of
Bax/Bcl-xL (B) and Bax/Bcl-2 (C) were determined by densitometric analysis of
bands from Western blot. P< 0.05 versus PDT alone.HK-1, LY294002- or PD98059-treated HK-1 cells. Results in
Figure 5B showed that pre-treatment of HK-1 cells with inhibitor
significantly increased the percentage of apoptotic cells from 33.7%
in the PDT group to 62.5% (PDTþ LY294002) and 57.8%
(PDTþ PD98059) (P< 0.05). Results from these studies indicated
that PDT-induced apoptosis could be enhanced through the
pharmacological inhibition of EGFR/PI3K/Akt or EGFR/MEK/ERK
pathways.
ROLE OF Bcl-2 FAMILY PROTEINS IN COMBINED AG1478
AND PDT-INDUCED APOPTOSIS
The impact of combined EGFR pathway inhibition and PDT on the
expression of Bcl-2 family proteins was then examined. HK-1 cells
were incubated with Zn-BC-AM for 24 h and then subjected to 1 h
pre-treatment of AG1478, LY294002 or PD98059 before light
irradiation. The expression of anti-apoptotic (Bcl-2 and Bcl-xL) and
pro-apoptotic (Bax) proteins were examined at 4 h post-PDT. Results
showed that AG1478, LY294002, and PD98059 alone slightly
increased the ratio of Bax/Bcl-xL in HK-1 cells (Fig. 6). A sevenfold
increase in Bax/Bcl-xL ratio was observed in cells after PDT. The
ratio was further increased after the combined treatment with
inhibitors and PDT. Similarly, the Bax/Bcl-2 ratio was also increased
twofold in HK-1 cells receiving the combined treatment. These
observations clearly indicated that the enhanced apoptotic effect of
combined Zn-BC-AM PDT and inhibition of EGFR pathways might
be due to the increase in Bax/Bcl-2 and Bax/Bcl-xL ratios.
DISCUSSION
Overexpression of EGFR in various cancer cells, including the NPC
cells, is often resulted in the promotion of malignant transformation
and tumor growth by inhibiting the apoptotic mechanism [Baselga,
2001, 2002; El RayesQ4 and LoRusso, 2004]. Previous study showed
that reduction of EGFR protein expression was correlated with the
anti-proliferative effects of silicon phthalocyanine (Pc4)-PDT on
A431 cells [Ahmad et al., 2001]. In the in vivo study, a regimen of
combined cetuximab and benzoporphyrin derivative monoacid A
(BPD)-PDT was found to improve the survival of tumor bearing mice
[del Carmen et al., 2005]. Despite inhibition of EGFR signaling
pathway by pharmacological specific inhibitors was found to
effectively induce cell cycle arrest and suppress cell proliferation in
different NPC cell lines [Zhu et al., 2001; Sung et al., 2005; Huang
et al., 2007], the effect of targeting EGFR in PDT-induced cell death
had not been fully elucidated. Results presented in the present study
represent the first experimental study to evaluate the efficacy of
combination of EGFR inhibitor and PDT on the death of NPC cells.
We showed that constitutively expressed phosphorylation of EGFR
could be inhibited by a sub-lethal concentration of AG1478.
Augmentation of cell death was found when the cells were treated
with a combination of AG1478 and Zn-BC-AM PDT. Our results
further demonstrated that the inhibition of EGFR could also enhance
apoptosis of the HK-1 cells, as judged from the increased in
apoptotic cells as well as the early appearance of the cleaved form of
executioner caspase-3. The implication of early appearance of the
cleaved caspase-3 and the increased in apoptosis is worthy to6 NASOPHARYNGEALQ2 CARCINOMA CELLSdiscuss. In general, apoptosis is an irreversible process. However,
chemotherapeutic drug-treated tumor cells may recover and even
survive after the initiation of apoptosis [Tang et al., 2009]. It is well
known that oxidative stress (e.g., singlet oxygen) is generated during
photoactivation of the photosensitizer. In AG1478þ PDT-treated
HK-1 cells, it is probably that all the cell death signals, namely the
oxidative stress caused by PDT and inhibition of the survival
pathways caused by AG1478, are delivered to the cell and initiate
the process of apoptosis (including the activation of caspase-3)
shortly after the treatment. As a result of this, the damaged cells may
not be able to repair the damage and recover within a short period of
time.
PI3K/Akt is one of the major survival pathways regulated by
EGFR [Yarden, 2001; HensonQ5 et al., 2006]. Akt regulates cell
survival through phosphorylation of the downstream targets
including apoptotic proteins, transcription factors and protein
kinases [Datta et al., 1999; Henson and Gibson, 2006]. Activation ofJOURNAL OF CELLULAR BIOCHEMISTRY
Akt has been demonstrated in human breast cancer cell treated with
photofrin-PDT [Bozkulak et al., 2007]. In the present study, increase
in p-Akt was observed in HK-1 cells after PDT. The presence of
activated Akt in cells undergoing cell death is worthy to discuss. The
increased in p-Akt was previously explained as a survival response
counteracting the cell death caused by oxidative stress [Zhuang and
Kochevar, 2003]. Maddika et al. [2008] recently found that the anti-
cancer drugs methotrexate and docetaxel would activate Akt and
enhance the cell death process. The pro-apoptotic effect of p-Akt
was attributed to the constitutively phosphorylation of CDK2 and
the subsequent disruption of cell cycle control through the
cytoplasmic sequestration of CDK2 to the cytoplasm. In another
study, activation of Akt was also demonstrated in cells undergoing
apoptosis [van Gorp et al., 2006]. All these studies indicate that Akt
plays a dual role in cells and activated p-Akt can be detected in cells
undergoing apoptosis. In the presence study, an increased in p-Akt
was observed at 4 h after PDT. Further functional study showed that
PDT-induced apoptosis of HK-1 cells was significantly increased by
the Akt inhibitor LY294002. Based on this observation, the increased
expression of p-Akt in PDT-treated HK-1 cells may be explained as a
survival response counteracting the cell death process.
In addition to the Akt pathway, EGFR signaling is also known to
activate ERKs through the cascades of Ras/MEK/ERK [Henson and
Gibson, 2006]. ERKs, one of the members of mitogen-activated
protein kinase (MAPKs), are highly sensitive to different stimuli. In
the present study, pharmacological inhibition of ERKs with
PD98059 also enhanced the PDT-induced cell death as well as
apoptosis of HK-1 cells. All these results suggested that both Akt and
ERKs were involved in AG1478 mediated augmentation of PDT-
induced cell death process.
It had been previously demonstrated that ionizing radiation
would suppress the expression of Bcl-2 and inhibit EGFR signaling
in various cancer cell lines [Bianco et al., 2002]. Inhibition of EGFR
also promoted paclitaxel-induced Bcl-2 down-regulation via the
EGFR/ERK-dependent but Akt-independent pathways in renal cell
carcinoma, resulting in the enhancement of apoptosis [Sumitomo
et al., 2004]. In the present study, Zn-BC-AM PDT was found to
reduce the expression of Bcl-xL and Bcl-2 in PDT-treated HK-1 cells.
In contrast, the expression of pro-apoptotic Bax protein was further
increased after the combined treatment with both PDT and the EGFR
inhibitor. The balance between the expression of anti-apoptotic
proteins (e.g., Bcl-2, Bcl-xL) and pro-apoptotic proteins (e.g., Bax) is
one of the important indicators to determine the cell fate. In the
steady state, Bcl-2 and/or Bcl-xL antagonizes Bax from triggering
apoptotic signals by oligomerization on the outer membrane of
mitochondria [Hsu and Youle, 1997; Mikhailov et al., 2001].
Therefore, the increase in the ratios of Bax/Bcl-xL and Bax/Bcl-2
would facilitate Bax to undergo active conformational change and
subsequently induce mitochondrial membrane permeabilization
[Gross et al., 1999]. The increase in Bax/Bcl-xL and Bax/Bcl-2 ratios
might explain the apoptosis-enhancing effect of EGFR inhibitor in
PDT-treated HK-1 cells. These observations suggest that the efficacy
of PDT on NPC cells can further be improved by chemotherapeutic
agents targeting the EGFR and the associated downstream pathways.
In summary, the present study evaluated the efficacy and the
underlying mechanisms of combined EGFR inhibitor and Zn-BC-JOURNAL OF CELLULAR BIOCHEMISTRYAM PDT on the HK-1 NPC cells. The efficacy of Zn-BC-AM PDT was
increased through the inhibition of EGFR/PI3K/Akt and EGFR/MEK/
ERK signaling pathways in HK-1 cells. Combination therapy of
Zn-BC-AM PDT with EGFR inhibitors may further be developed for
the treatment of NPC.ACKNOWLEDGMENTS
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